FDA approves first cell-culture vaccine for seasonal influenza
FDA approved Influenza Virus Vaccine (Flucelvax, Novartis Vaccines), the first cell-culture-derived vaccine, for individuals aged 18 years of age and older.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
